The regulation of CD4+ T cell immune responses toward Th2 cell development by prostaglandin E2

International Immunopharmacology

Volumn 11, Issue 10, 2011, Pages 1599-1605

  Bao, Yu Shi ^a   Zhang, Ping ^b   Xie, Ru Juan ^a   Wang, Mei ^c   Wang, Zhi Yong ^d   Zhou, Zheng ^c   Zhai, Wen Jing ^c   Feng, Si Zhou ^c   Han, Ming Zhe ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b SHANDONG UNIVERSITY   (China)

^c INSTITUTE OF HEMATOLOGY AND BLOOD DISEASES HOSPITAL   (China)

^d ZIBO CENTRAL HOSPITAL   (China)

Author keywords

CD4+ T cell; Cytokine; Immune responses; Prostaglandin E2

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 2; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE; PROSTAGLANDIN E2; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DOWN REGULATION; DRUG POTENCY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IMMUNOREGULATION; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TH1 CELL; TH2 CELL; UPREGULATION;

CD4-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; DINOPROSTONE; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; IMMUNITY, CELLULAR; IMMUNOMODULATION; NF-KAPPA B; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SIGNAL TRANSDUCTION; TH1-TH2 BALANCE; TH2 CELLS;

EID: 80053289160     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.05.021     Document Type: Article

References (19)

1. S.G. Harris, J. Padilla, and L. Koumas Prostaglandins as modulators of immunity Trends Immunol 23 2002 144 150 (Pubitemid 34178297)
2. A.J. Nauta, and W.E. Fibbe Immunomodulatory properties of mesenchymal stromal cells Blood 15 2007 3499 3506 (Pubitemid 350159613)
3. H. Shiraishi, H. Yoshida, and K. Saeki Prostaglandin E2 is a major soluble factor produced by stromal cells for preventing inflammatory cytokine production from dendritic cells Int Immunol 20 2008 1219 1229
4. S. Beyth, Z. Borovsky, and D. Mevorach Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness Blood 105 2005 2214 2219 (Pubitemid 40731815)
5. Bianca Rocca, Garret A, Cyclooxygenase and prostaglandins: shaping up the immune response. International Immunopharmacology 2002; 603-30. (Pubitemid 34246363)
6. Y. Fujimoto, H. Iwagaki, and M. Ozaki Involvement of prostaglandin receptors (EPR2-4) in in vivo immunosuppression of PGE2 in rat skin transplant model Int Immunopharmacol 5 2005 1131 1139 (Pubitemid 40725708)
7. + T regulatory cell activities in lung cancer Cancer Res 65 2005 5211 5220 (Pubitemid 40827331)
8. 2 secretion in patients with breast cancer Ann Surg Oncol 11 2004 328 339 (Pubitemid 40486775)
9. Parris Kidd Th1/Th2 balance: the hypothesis, its limitations, and implications for health and disease Altern Med Rev 8 2003 223 246 (Pubitemid 37099886)
10. F. Baratelli, Y. Lin, and L. Zhu Prostaglandin E2 induces FOXP3 gene expression and T regulatory cell function in human CD4+ T cells J Immunology 175 2005 1483 1490 (Pubitemid 41023048)
11. Matthew D. Woolard, and Justin E. Wilson Francisella tularensis-infected macrophages release prostaglandin E2 that blocks T cell proliferation and promotes a Th2-like response1 J Immunol 178 2007 2065 2074 (Pubitemid 46233403)
12. Hyeon Joo Cheon, Young Hee Rho, and Seong Jae Choi Prostaglandin E2 augments IL-10 signaling and function J Immunol 177 2006 1092 1100 (Pubitemid 44036612)
13. E.M. Aandahl, W.J. Moretto, and P.A. Haslett Inhibition of antigen-specific T cell proliferation and cytokine production by protein kinase A type I J Immunol 169 2002 802 808 (Pubitemid 34753436)
14. S. Gerlo, P. Verdood, and B. Gellersen Mechanism of prostaglandin (PG) E2-induced prolactin expression in human T cells: cooperation of two PGE2 receptor subtypes, E-prostanoid (EP) 3 and EP4, via calcium- and cyclic adenosine 5′-monophosphate-mediated signaling pathways J Immunol 173 2004 5952 5962 (Pubitemid 39487749)
15. N. Kvirkvelia, I. Vojnovic, and T.D. Warner Placentally derived prostaglandin E2 acts via the EP4 receptor to inhibit IL-2-dependent proliferation of CTLL-2 T cells Clin Exp Immunol 127 2002 263 269 (Pubitemid 34233931)
16. N. Takahashi, T. Tetsuka, and H. Uranishi Inhibition of the NF-kappaB transcriptional activity by protein kinase A Eur J Biochem 269 2002 4559 4565
17. A.M. Thornton, E.E. Donovan, and C.A. Piccirillo Cutting edge: IL-2 is critically required for the in vitro activation of CD4+ CD25+ T cell suppressor function J Immunol 172 2004 6519 6523 (Pubitemid 38669083)
18. W.B. Lindsey, M.W. Lowdell, and G.E. Marti CD69 expression as an index of T-cell function: assay standardization, validation and use in monitoring immune recovery Cytotherapy 9 2007 123 132 (Pubitemid 46510977)
19. T. Morichika, H.K. Takahashi, and H. Iwagaki Effect of prostaglandin E2 on intercellular adhesion molecule-1 and B7 expression in mixed lymphocyte reaction Transplantation 75 2003 2100 2105 (Pubitemid 36793300)